Glutenostics Launches Gluten Detective, the First At-Home Gluten Consumption Monitoring Test

Print Friendly, PDF & Email

For many patients living with celiac disease or non-celiac gluten/wheat sensitivity, the emergence of almost any new or recurring symptom, even when adhering to a gluten-free diet as instructed, causes anxiety and distress. A new self-administered, home test kit called Gluten Detective, released under license by Glutenostics LLC and developed by a Spanish company, empowers patients and caregivers to determine whether they have consumed any gluten in the past 24-48 hours.

This is an important new product for celiac disease and non-celiac gluten/wheat sensitive patients. Celiac Disease Foundation is proud to support Glutenostics in their efforts to bring information about this valuable new development to the celiac disease and non-celiac gluten/wheat sensitive community.

To order Gluten Detective, CLICK HERE.

Glutenostics Launches Gluten Detective, the First At-Home Gluten Consumption Monitoring Test

LOS ANGELES, California (November 6th, 2017)

Glutenostics LLC formally announced today the launch of their first product line, Gluten Detective, a rapid test suite for people on the gluten-free diet (GFD) to monitor compliance. In just 15 minutes or more, in the privacy of a bathroom anywhere in the world, people are now able to sample their urine or stool to detect gluten fragments indicative of gluten consumption over the previous 1-2 or more days. “This revolutionary and one-of-a-kind technology will empower people to take control of their gluten-free life and improve adherence to the diet through scientifically informed decision making,” states David Winternheimer, PhD, CEO of Glutenostics. “Whatever your motive for maintaining gluten-free living, Gluten Detective is a flexible monitoring tool to provide valuable insight into your dietary composition, and afford users peace of mind.”

The technology basis of Gluten Detective was developed by a company in Seville, Spain (Biomedal), where over a decade of research and development was invested in the innovation of these game-changing products. As an integral part of the worldwide roll-out of both lab- and home-based testing products for gluten, Glutenostics is responsible for the commercialization of these tests in the USA and Canada, where they are the exclusive licensee and distributor of the technology.

“Glutenostics is transforming the way people live gluten-free,” states Dr. Winternheimer, “both with these novel tests and assessment of future product opportunities in our pipeline.” In collaboration with industry-leading key opinion leaders and non-profit partners, Glutenostics is working to change the landscape of the gluten-free space. “Today we are also proud to announce our new investor, cited as the most successful biotech entrepreneur in Germany, Patrick Baeuerle. With our outstanding team of advisors, executives and partners, we are optimistic of Glutenostics’ ability to positively impact the gluten-free community.”

About Glutenostics LLC
Glutenostics was founded in 2016 with the mission of bringing new technologies to market that improve the livelihood of those living gluten-free, regardless of reason. In 2017, Glutenostics licensed their first technology from Biomedal (Seville, Spain), and developed their first product line, Gluten Detective, now available exclusively via their website www.glutendetective.com As Glutenostics continues to grow and expand, it continues to pursue partnerships with other technology innovators in the gluten-free and surrounding space to commercialize those products in North America.

Glutenostics Launches Gluten Detective, the First At-Home Gluten Consumption Monitoring Test

Tags: